Is Testing for Cytomegalovirus and Cystic Fibrosis Indicated in Members of a Nonwhite Pregnant Population in Whom the Fetus Has an Echogenic Bowel?

ABSTRACT

The purpose of this study was to determine whether testing for cystic fibrosis (CF) and cytomegalovirus (CMV) infection is necessary in African-American and Hispanic gravidas in whom the fetus had an echogenic bowel. This retrospective study consisted of only African American and Hispanic patients in whom the fetus had an echogenic bowel, referred to the Maternal and Fetal Medicine unit at New Jersey Medical School for a specialized ultrasound, between June 30, 2004, and March 31, 2005. Sixty-five patients met the inclusion criteria for our study. Maternal serum testing for CF was done in 32 patients and all newborns were screened for the disease. There were no positive results for CF. CMV serology was tested in 38 patients and there were no cases of acute congenital CMV infection. In our population of 65 patients, there was one intrauterine growth restricted (IUGR) fetus and five intrauterine fetal demise (IUFD). Although all patients who were tested for CMV infection tested negative, the true incidence in our selected population may be underestimated because some of our patients were not tested. There were no cases of congenital CMV infection and all newborn screening tests for CF were negative. Prenatal diagnosis of fetal echogenic bowel was associated with a 7.6% incidence of IUFD and 1.6% incidence of IUGR.

cytomegalovirus - Cystic fibrosis - echogenic bowel

REFERENCES

• 1 Hill L M, Fries J, Hecker J, Grysbeck P. Second trimester echogenic small bowel: an increased risk for adverse perinatal outcome.  Prenat Diagn. 1994;  14 845-850
• 2 Dicke J M, Crane J P. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management.  Obstet Gynecol. 1992;  80 778-782
• 3 Nyberg D A, Dubinsky T, Resta R G, Mahony B S, Hickok D E, Luthy D A. Echogenic fetal bowel during the second trimester: clinical importance.  Radiology. 1993;  188 527-531
• 4 Slotnick R N, Abuhamad A Z. Prognostic implications of echogenic fetal bowel.  Lancet. 1996;  347 85-87
• 5 Penna L, Bower S. Hyperechogenic bowel in the second trimester fetus: a review.  Prenat Diagn. 2000;  20 909-913
• 6 Fakhry J, Reisner M, Shariro L R, Schechter A, Pait L P, Glennon A. Increased echogenicity in the lower fetal abdomen: a common normal variant in the second trimester.  J Ultrasound Med. 1986;  5 489-492
• 7 Scioscia A L, Pretorius D H, Budorick N E, Cahill T C, Axelrod F T, Leopold G R. Second-trimester echogenic bowel and chromosomal abnormalities.  Am J Obstet Gynecol. 1992;  167 889-894
• 8 Bromley B, Doubilet P, Frigoletto F D, Krauss C, Estroff J A, Benacerraf B R. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis?.  Obstet Gynecol. 1994;  83 647-651
• 9 Caspi B, Elchalal U, Lancet M, Chemke J. Prenatal diagnosis of cystic fibrosis: ultrasonographic appearance of meconium ileus in the fetus.  Prenat Diagn. 1988;  8 379-382
• 10 MacGregor S N, Tamura R, Sabbagha R, Brenhofer J K, Kambich M P, Pergament E. Isolated hyperechoic fetal bowel: significance and implications for management.  Am J Obstet Gynecol. 1995;  173 1254-1258
• 11 Ferriman E L, Mason G, Ellis L. Risk of cystic fibrosis with prenatally detected echogenic bowel.  Prenat Diagn. 1999;  19 1177
• 12 Muller F, Dommergues M, Simon-Bouy B et al.. Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case.  J Med Genet. 1998;  35 657-660
• 13 Sepulveda W, Leung K Y, Robertson M E, Kay E, Mayall E S, Fisk N M. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.  Obstet Gynecol. 1996;  87 103-106
• 14 Scotet V, De Braekeleer M, Audrezet M P et al.. Prenatal detection of cystic fibrosis by ultrasonography: a retrospective study of more than 346 000 pregnancies.  J Med Genet. 2002;  39 443-448
• 15 Forouzan I. Fetal abdominal echogenic mass: an early sign of intrauterine cytomegalovirus infection.  Obstet Gynecol. 1992;  80 535-537
• 16 Enders G, Bader U, Lindemann L, Schalasta G, Daiminger A. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome.  Prenat Diagn. 2001;  21 362-377 , [Erratum: Prenat Diagn 2001;21:605]
• 17 Rousseau T, Douvier S, Reynaud I et al.. Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy.  Prenat Diagn. 2000;  20 333-336
• 18 Sepulveda W, Leung K Y, Robertson M E, Kay E, Mayall E S, Fisk N M. Prevalence of cystic fibrosis mutations in pregnancies with fetal echogenic bowel.  Obstet Gynecol. 1996;  87 103-106
• 19 Hodge S E, Lebo R V, Yesley A R, Cherney S M, Angle H, Milunsky J. Calculating posterior cystic fibrosis risk with echogenic bowel and one characterized cystic fibrosis mutation: avoiding the pitfalls in the risk calculations.  Am J Med Genet. 1999;  82 329-335
• 20 Watson M S, Cutting G R, Desnick R J et al.. Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel.  Genet Med. 2004;  6 387-391
• 21 Palomaki G E, FitzSimmons S C, Haddow J E. Clinical sensitivity of prenatal screening for cystic fibrosis via CFTR carrier testing in a United States panethnic population.  Genet Med. 2004;  6 405-414
• 22 Stagno S. Cytomegalovirus. In: Remington JS, Klein J, Baker C, Wilson C Infectious Diseases of the Fetus and Newborn Infant. Philadelphia, PA; WB Saunders 1995: 312-353
• 23 Stagno S, Pass R F, Dworsky M E et al.. Congenital cytomegalovirus infection: the relative importance of primary and recurrent maternal infection.  N Engl J Med. 1982;  306 945-949
• 24 Stagno S, Pass R F, Cloud G et al.. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus and clinical outcome.  JAMA. 1986;  256 1904-1908
• 25 Fowler K B, Stagno S, Pass R, Britt W J, Boll T J, Alford C A. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status.  N Engl J Med. 1992;  326 663-667
• 26 Duff P. Cytomegalovirus infection in pregnancy.  Infect Dis Obstet Gynecol. 1994;  2 146-152
• 27 Peters M T, Lowe T W, Carpenter A, Kole S. Prenatal diagnosis of congenital cytomegalovirus infection with abnormal triple-screen results and hyperechoic fetal bowel.  Am J Obstet Gynecol. 1995;  173 953-954
• 28 Yaron Y, Hassan S, Geva E, Kupferminc M J, Yavetz H, Evans M I. Evaluation of fetal echogenic bowel in the second trimester.  Fetal Diagn Ther. 1999;  14 176-180
• 29 Bromley B, Doubilet P, Frigoletto F D, Krauss C, Estroff J A, Benacerraf B R. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis?.  Obstet Gynecol. 1994;  83 647-651
• 30 Ghose I, Mason G C, Martinez D et al.. Hyperechogenic fetal bowel: a prospective analysis of sixty consecutive cases.  BJOG. 2000;  107 426-429
• 31 Simon-Bouy B, Satre V, Ferec C French Collaborative Group et al.. Hyperechogenic fetal bowel: a large French collaborative study of 682 cases.  Am J Med Genet A. 2003;  121 209-213